313 studies found for:    Open Studies | "Urinary Bladder Diseases"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting A Phase 2 Study of B-701 in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
Conditions: Locally Advanced or Metastatic Urothelial Cell Carcinoma;   Urinary Bladder Disease;   Urological Diseases
Interventions: Drug: B-701;   Drug: Docetaxel;   Drug: placebo
2 Recruiting A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
Conditions: Overactive Bladder;   Urinary Bladder Overactive;   Urinary Bladder Diseases;   Urologic Diseases
Interventions: Drug: mirabegron;   Drug: antimuscarinic medication
3 Not yet recruiting 3D HD Versus 2D HD in Cholecystectomy
Conditions: Cholelithiasis;   Gall Bladder Disease
Interventions: Device: 3D HD laparoscopy;   Device: 2D HD laparoscopy
4 Unknown  Prospective Multicenter Human Randomized Controlled Evaluation of NOTES® Cholecystectomy
Condition: Gall Bladder Diseases
Interventions: Procedure: NOTES Cholecystectomy;   Procedure: Laparoscopic Cholecystectomy
5 Recruiting Vicinium Treatment for Subjects With High-grade Non-muscle Invasive Bladder Cancer Previously Treated With BCG
Condition: Bladder Cancer
Intervention: Biological: Vicinium
6 Unknown  Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy
Condition: Bladder Exstrophy
Intervention:
7 Recruiting Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
Conditions: Bladder Cancer;   Carcinoma, Transitional Cell;   Renal Pelvis Cancer;   Ureter Cancer;   Urethra Cancer
Interventions: Drug: Enzalutamide;   Drug: Cisplatin;   Drug: Gemcitabine
8 Recruiting Pre-TURBT TC-3 Gel Intravesical Instillation in NMIBC
Condition: Carcinoma of Urinary Bladder, Superficial
Interventions: Device: 40 mg MMC gel;   Other: Standard of care MMC mixed with water;   Device: 80 mg MMC gel
9 Recruiting Do Patient Anxiety Levels Decrease Urodynamic Test Reproducibility?
Conditions: Anxiety;   Overactive Bladder;   Urinary Incontinence, Stress;   Urinary Incontinence, Urge;   Urinary Retention
Intervention:
10 Not yet recruiting Comparisons of the Effects of Solifenacin Versus Mirabegron on Autonomic System, Arterial Stiffness and Psychosomatic Distress and Clinical Outcomes
Condition: Overactive Bladder Syndrome
Interventions: Drug: solifenacin;   Drug: mirabegron
11 Not yet recruiting Quantitative Evaluation of Cytokeratin in the Urine of Spinal Cord Individuals With Suspicion of Bladder Cancer
Conditions: Bladder Cancer;   Spinal Cord Injury
Intervention: Other: measurement of cytokeratin concentration in urine
12 Not yet recruiting Mirabegron in Parkinson Disease and Impaired Cognition
Conditions: Parkinson Disease;   Overactive Bladder;   Impaired Cognition
Interventions: Drug: mirabegron;   Drug: Placebo
13 Not yet recruiting A Study of the Effect of Antibiotics on the Microbiology of the Bladder in Patients With Overactive Bladder
Condition: Urogynaecology
Intervention: Other: None - this is a prospective observational study. Patients will be prescribed their usual treatment (antibiotics) and the effect on urine studied
14 Not yet recruiting Postoperative Quality of Recovery After Transurethral Resection of the Bladder
Conditions: Urinary Bladder Neoplasms;   Transurethral Resection of the Bladder;   Postoperative Recovery
Interventions: Procedure: Spinal anesthesia;   Procedure: General anesthesia;   Drug: bupivacaine;   Drug: fentanyl;   Drug: propofol;   Drug: sevoflurane
15 Not yet recruiting Study of Tremelimumab in Patients With Advanced Solid Tumors
Condition: UBC (Urothelial Bladder Cancer)/ TNBC (Triple-negative Breast Cancer)/ PDAC (Pancreatic Ductal Adenocarcinoma)
Interventions: Biological: Tremelimumab monotherapy;   Biological: MEDI4736 monotherapy;   Biological: MEDI4736 + tremelimumab combination therapy
16 Not yet recruiting A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 5 to Less Than 12 Years of Age With Neurogenic Detrusor Overactivity (NDO) or Overactive Bladder (OAB)
Conditions: Neurogenic Detrusor Overactivity;   Overactive Bladder
Intervention: Drug: mirabegron
17 Not yet recruiting The Estrogen Impact on Overactive Bladder Syndrome: Female Pelvic Floor Microbiomes and Antimicrobial Peptides
Condition: Overactive Bladder
Intervention: Drug: conjugated estrogen
18 Recruiting Use of Preemptive Pudendal Nerve Block Prior to Hydrodistention for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Conditions: Interstitial Cystitis;   Painful Bladder Syndrome
Interventions: Drug: Lidocaine;   Drug: Placebo
19 Not yet recruiting Study of MEDI4736 With or Without Tremelimumab Versus Standard of Care Chemotherapy in Bladder Cancer
Condition: Bladder Cancer
Interventions: Drug: MEDI4736;   Drug: Tremelimumab;   Drug: Cisplatin;   Drug: Carboplatin;   Drug: Gemcitabine
20 Recruiting Trans-MAPP Symptom Patterns Study (SPS)
Conditions: Interstitial Cystitis;   Chronic Prostatitis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years